9 search results
GlaxoSmithKline to shut down Shanghai R&D lab
Despite a former status as a hub of scientific innovation, GlaxoSmithKline is set to close its Shanghai R&D centre. The lab had been leading GSK...
GlaxoSmithKline to sell Horlicks and halt Cumbrian facility
GlaxoSmithKline is set to downsize in the UK. In a bid to reorganise its British manufacturing network, GSK is abandoning plans to create a new facilit...
GSK invests $120mn in biopharmaceutical manufacturing facility
GlaxoSmithKline (GSK) has announced a $120mn investment to expand its US manufacturing facility in Upper Merion. The move is part of a $400mn scheme to...
New GSK CEO to become the most powerful woman in FTSE 100
Emma Walmsley is set to become the most powerful woman in the FTSE 100. Within the Financial Times Stock Exchange index of the top 100 UK companies...
GSK to invest further in the UK
Despite the limbo-like state of the UK economy, GlaxoSmithKlineis planning to continue British investment. Adrian Tombling, Patent Attorney and Head...